![Frontiers | A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease | Cellular Neuroscience Frontiers | A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease | Cellular Neuroscience](https://www.frontiersin.org/files/Articles/70271/fncel-08-00050-HTML/image_m/fncel-08-00050-g001.jpg)
Frontiers | A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease | Cellular Neuroscience
![Enhanced in vivo targeting of estrogen receptor alpha signaling in murine mammary adenocarcinoma by nilotinib/rosuvastatin novel combination - ScienceDirect Enhanced in vivo targeting of estrogen receptor alpha signaling in murine mammary adenocarcinoma by nilotinib/rosuvastatin novel combination - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0041008X20303112-ga1.jpg)
Enhanced in vivo targeting of estrogen receptor alpha signaling in murine mammary adenocarcinoma by nilotinib/rosuvastatin novel combination - ScienceDirect
![Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer | EMBO Molecular Medicine Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/6de6435b-d3b2-4ffc-becf-560b51afaed5/emmm201707918-fig-0004-m.jpg)
Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer | EMBO Molecular Medicine
![Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein | Leukemia Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2014.21/MediaObjects/41375_2014_Article_BFleu201421_Fig1_HTML.jpg)
Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein | Leukemia
![Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective. - Abstract - Europe PMC Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3922331/bin/1756-9966-33-15-1.jpg)
Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective. - Abstract - Europe PMC
![Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram](https://www.researchgate.net/profile/Charles-Ashby-Jr/publication/44662876/figure/fig1/AS:337835585490944@1457557688178/Schematic-representation-of-the-mechanism-of-action-of-the-BCR-ABLTKIs-The-BCR-ABL.png)
Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram
![Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/277486ae-370f-4b4c-8802-b34f748385a3/301ga1.jpg)
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology
![Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases - ScienceDirect Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167488913000918-gr12.jpg)
Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases - ScienceDirect
![Cells | Free Full-Text | Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy | HTML Cells | Free Full-Text | Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy | HTML](https://www.mdpi.com/cells/cells-08-00506/article_deploy/html/images/cells-08-00506-g003b.png)
Cells | Free Full-Text | Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy | HTML
![Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer | EMBO Molecular Medicine Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/90f70e57-3b7d-4357-8a4f-e6be4ab8ce1a/emmm201707918-fig-0008-m.jpg)